[1]. Maughan RJ, Watson JS, Weir J. Strength and crosssectional area of human skeletal muscle. J Physiol 1983; 338:37-49.
[2]. Wisløff U, Castagna C, Helgerud J, Jones R, Hoff J. Strong correlation of maximal squat strength with sprint performance and vertical jump height in elite soccer players. British journal of sports medicine. Br J Sports Med 2004; 38(3):285-8.
[3]. Volaklis KA, Halle M, Meisinger C. Muscular strength as a strong predictor of mortality: a narrative review. European journal of internal medicine. Eur J Intern Med 2015; 26(5):303-10.
[4]. McPherron AC, Lawler AM, Lee SJ. Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member. Nature 1997; 387(6628):83-90.
[5]. Zimmers TA, Davies MV, Koniaris LG, Haynes P, Esquela AF, Tomkinson KN, et al. Induction of cachexia in mice by systemically administered myostatin. Science 2002; 296(5572):1486-8.
[6]. Rodriguez J, Vernus B, Chelh I, Cassar-Malek I, Gabillard JC, Sassi AH, et al. Myostatin and the skeletal muscle atrophy and hypertrophy signaling pathways. Cell Mol Life Sci 2014; 71(22):4361-71. [7]. Hill JJ, Qiu Y, Hewick RM, Wolfman NM. Regulation of myostatin in vivo by growth and differentiation factorassociated serum protein-1: a novel protein with protease inhibitor and follistatin domains. Mol Endocrinol 2003; 17(6):1144-54.
[8]. Hansen J, Brandt C, Nielsen AR, Hojman P, Whitham M, Febbraio MA, et al. Exercise induces a marked increase in plasma follistatin: evidence that follistatin is a contractioninduced hepatokine. Endocrinology 2011;152(1):164-71.
[9]. Gilson H, Schakman O, Kalista S, Lause P, Tsuchida K, Thissen JP. Follistatin induces muscle hypertrophy through satellite cell proliferation and inhibition of both myostatin and activin. Am J Physiol Endocrinol Metab 2009; 297(1):E157-E64.
[10]. Haff GG, Triplett NT. Essentials of strength training and conditioning 4th edition: Human kinetics; 2015.
[11]. Saremi A, Gharakhanloo R, Sharghi S, Gharaati M, Larijani B, Omidfar K. Effects of oralcreatine and resistance training on serum myostatin and GASP-1. Mol Cell Endocrinol 2010; 317(1-2):25-30.
[12]. Jensky NE, Sims JK, Dieli-Conwright CM, Sattler FR, Rice JC, Schroeder ET. Exercise does not influence myostatin and follistatin messenger RNA expression in young women. J Strength Cond Res 2010; 24(2):522.-30.
[13]. Willoughby DS. Effects of heavy resistance training on myostatin mRNA and protein expression. Med Sci Sports Exerc 2004; 36(4):574-82.
[14]. Mafi F, Biglari S, Ghardashi Afousi A, Gaeini AA. Improvement in skeletal muscle strength and plasma levels of follistatin and myostatin induced by an 8-week resistance training and epicatechin supplementation in sarcopenic older adults. J Aging Phys Act 2019; 27(3):38491.
[15]. Negaresh R, Ranjbar R, Baker JS, Habibi A, Mokhtarzade M, Gharibvand MM, et al. Skeletal muscle hypertrophy, insulin-like growth factor 1, myostatin and follistatin in healthy and sarcopenic elderly men: The effect of wholebody resistance training. Int J Prev Med 2019; 10:29.
[16]. Janot J, Heltne T, Welles C, Riedl J, Anderson H, Howard A, et al. Effects of TRX versus traditional resistance training programs on measures of muscular performance in adults. J Fitness Res 2013; 2(2):23-38.
[17]. Campa F, Silva AM, Toselli S. Changes in phase angle and handgrip strength induced by suspension training in older women. Int J Sports Med 2018; 39(6):442-9.
[18]. Roth SM, Martel GF, Ferrell RE, Metter EJ, Hurley BF, Rogers MA. Myostatin gene expression is reduced in humans with heavy-resistance strength training: a brief communication. Exp Biol Med (Maywood) 2003; 228(6):706-9.
[19]. Mafi F, Biglari S, Afousi A, Gaeini AA. Epicatechin supplementation and resistance training-induced improvement of muscle strength and circulatory levels of plasma follistatin and myostatin in sarcopenic older adults. J aging physical activity 2018; 27(3):1-27.
[20]. Schwarz NA, McKinley-Barnard SK, Spillane MB, Andre TL, Gann JJ, Willoughby DS. Effect of resistance exercise intensity on the expression of PGC-1α isoforms and the anabolic and catabolic signaling mediators, IGF-1 and myostatin, in human skeletal muscle. Appl Physiol Nutr Metab 2016; 41(8):856-63.
[21]. Aguilera-Castells J, Buscà B, Fort-Vanmeerhaeghe A, Montalvo AM, Peña J. Muscle activation in suspension training: a systematic review. Sports Biomech 2018, 14:121.
[22]. Motevalli MS, Dalbo VJ, Attarzadeh RS, Rashidlamir A, Tucker PS, Scanlan AT. The effect of rate of weight reduction on serum myostatin and follistatin concentrations in competitive wrestlers. Int J Sports Physiol Perform 2015; 10(2):139-46.
[23]. Hofmann M, Schober-Halper B, Oesen S, Franzke B, Tschan H, Bachl N, et al. Effects of elastic band resistance training and nutritional supplementation on muscle quality and circulating muscle growth and degradation factors of institutionalized elderly women: the Vienna Active Ageing Study (VAAS). Eur J Appl Physiol 2016; 116(5):885-97.
[24]. Santos A, Lamas L, Ugrinowitsch C, Tricoli V, Miyabara EH, Soares A, et al. Different resistance-training regimens evoked a similar increase in myostatin inhibitors expression. Int J Sports Med. 2015;36(09):761-8.
[25]. Hansen JS, Pedersen BK, Xu G, Lehmann R, Weigert C, Plomgaard P. Exercise-induced secretion of FGF21 and follistatin are blocked by pancreatic clamp and impaired in type 2 diabetes. J Clin Endocrinol Metab 2016; 101(7):2816-25.